606 - Consumer Engagement Done Right: Designing Digital Health Experiences With Consumers
Why It Matters
Embedding authentic consumer engagement transforms digital health solutions from speculative ideas into validated, patient‑centered products, driving better outcomes and investor confidence.
Key Takeaways
- •True consumer engagement requires partnership, not just one‑way surveys.
- •Map entire patient journey to identify high‑impact digital interventions.
- •Use a simple framework: Listen, Define, Co‑create with lived‑experience users.
- •Validate problems with focus groups then scale to larger evidence base.
- •Embed engagement as a core capability, not a budget‑add‑on.
Summary
The Talking Health Tech podcast episode dives deep into consumer engagement for digital health, featuring Shelley Thompson, co‑founder of Patient Experience Agency. Thompson explains that genuine engagement goes beyond informing patients—it means partnering with them throughout design, implementation, and evaluation to shape services that truly meet their needs. Key insights include the importance of viewing the patient journey holistically, using human‑centered design tools like journey mapping, and recognizing a maturity spectrum where organizations evolve from one‑way surveys to continuous co‑creation. Thompson outlines a practical "Listen, Define, Co‑create" framework and stresses recruiting participants with relevant lived experience, not generic consumers. She highlights the double‑diamond methodology—deeply understanding the problem before proposing solutions—and cites common barriers: uncertainty about where to start, perceived time costs, fear of criticism, and the tendency to treat engagement as a budget add‑on. Real‑world examples, such as small focus groups expanding to larger validation studies, illustrate how to build an evidence base that convinces clinicians and investors alike. The takeaway for health‑tech firms is clear: embed consumer engagement as a core capability. Doing so reduces the risk of solving the wrong problem, accelerates adoption, and strengthens pitches to investors by grounding product claims in robust patient‑derived data.
Comments
Want to join the conversation?
Loading comments...